The Vet Group achieved strong revenue growth in FY25, with vet segment revenues rising 13% YoY to £655.1 million, highlighting its resilient, higher-margin contribution to the group. However, elevated living costs have squeezed discretionary spending, resulting in weaker retail sales and muted demand for pet accessories in FY25, with the retail segment unable to counteract mounting cost pressures.
Cyborg Score Rationale
Underlying pre-tax profit for the first half of FY26 fell by 33.5% to £36.2 million as retail profit dropped 84%, exposing ongoing weakness in the core retail business. While the veterinary division provides stability and growth, significant headwinds in retail and upcoming regulatory pressures create near-term uncertainty.
Top Insights
Vet division delivering 13% YoY growth with higher margins, partially offsetting retail weakness
FY26 profit guidance reduced to £115-125m versus prior FY25 levels due to subdued retail performance
New CEO appointed (James Bailey, effective March 30, 2026) to execute retail turnaround strategy
Substantial dividend yield of 6.43% supported by healthy free cash flow despite profit pressures
Named Competitors
B&Q Pet Division — Home improvement and pet supplies retailer
Amazon Pet Supplies — Online pet supplies and accessories
Independent Veterinary Practices — Local pet healthcare providers
Recent Developments
(January 2026) Appointment of James Bailey as Chief Executive Officer, effective March 30, 2026
(December 2025) H1 FY26 results show 33.5% profit decline with retail profit down 84%
(October 2025) Stock fell 3% on weak profit guidance and performance concerns
(FY25) Vet segment revenues grew 13% YoY to £655.1 million
Open the full interactive Pets at Home Group Plc report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.